SCHEMBL3042373

SCHEMBL3042373

COc1ccc(CNCc2ccccc2)cc1OC

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
MAPT P10636 2/20 0.69
HTT P42858 2/20 0.64
KMT2A Q03164 3/20 0.59
KDM4E B2RXH2 3/20 0.59
MEN1 O00255 1/20 0.59
POLB P06746 1/20 0.59
ALDH1A1 P00352 2/20 0.57
HPGD P15428 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
BCHE P06276 2/20 0.57
NPY1R P25929 1/20 0.57
NPY2R P49146 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29207901 0.93 SMN1; SMN2 (0.66) LMNASMN1; SMN2MAPTHTTKMT2A
SCHEMBL1599701 0.91 KDM4E (0.69) LMNASMN1; SMN2MAPTHTTKMT2A
SCHEMBL29484286 0.91 KDM4E (0.69) LMNASMN1; SMN2MAPTHTTKMT2A
SCHEMBL3051565 0.89 LMNA (0.74) LMNASMN1; SMN2HTTKMT2AKDM4E
SCHEMBL11063684 0.89 TTR (0.66) LMNASMN1; SMN2MAPTHTTKMT2A
SCHEMBL9416614 0.88 LMNA (0.73) LMNASMN1; SMN2HTTKMT2AKDM4E
SCHEMBL1966824 0.87 KDM4E (0.74) LMNASMN1; SMN2HTTKMT2AKDM4E
SCHEMBL5031143 0.87 BCHE (0.74) LMNASMN1; SMN2HTTKMT2AKDM4E
SCHEMBL7279400 0.85 ALDH1A1 (0.72) LMNASMN1; SMN2HTTKMT2AKDM4E
Hydrochloric Acid SCHEMBL11451398 0.85 KDM4E (0.72) LMNASMN1; SMN2HTTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
US-5621103-A 3-(SUBSTITUTED METHYLAMINOCARBONYL)-1,2,3,4-TETRAHYDRO-(1)BENZOTHIENO(2,3-C) PYRIDINES; ANXIOLYTIC AGENTS; LEARNING ENHANCEMENT ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1997-04-15 US disclosed
EP-0253327-B1 DIPHENYLPROPYLAMINE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1992-05-06 EP disclosed
EP-0253327-A2 Diphenylpropylamine derivatives, their preparation and their pharmaceutical use CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) 1988-01-20 EP disclosed
US-4435565-A ENZYME INHIBITORS BEECHAM GROUP LIMITED (GB) 1984-03-06 US disclosed
US-4359473-A α-Amino deoxy clavulanic acid antibacterial agents BEECHAM GROUP LIMITED (GB) 1982-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC LMNA 3312/4885SMN1; SMN2 4582/4885MAPT 4349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.